Laura Eggertson. Show Affiliations »
Abstract
Mesh: See more » CanadaCyclooxygenase Inhibitors/adverse effectsDrug Approval/legislation & jurisprudenceHumansProduct Surveillance, PostmarketingSingle-Payer SystemUnited StatesUnited States Food and Drug Administration
Substances: See more » Cyclooxygenase Inhibitors
Year: 2005 PMID: 15684107 PMCID: PMC545746 DOI: 10.1503/cmaj.045312
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262